SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $822,926 | -50.2% | 1,372,000 | +7.9% | 0.03% | -61.3% |
| Q2 2023 | $1,653,600 | -12.4% | 1,272,000 | +18.7% | 0.08% | -29.9% |
| Q1 2023 | $1,886,720 | -43.9% | 1,072,000 | 0.0% | 0.11% | -53.9% |
| Q4 2022 | $3,366,080 | +29.6% | 1,072,000 | +102.3% | 0.23% | -8.3% |
| Q3 2022 | $2,597,000 | +18.4% | 530,000 | 0.0% | 0.25% | +10.0% |
| Q2 2022 | $2,194,000 | +11.1% | 530,000 | +55.9% | 0.23% | -9.4% |
| Q1 2022 | $1,975,000 | +7.5% | 340,000 | +38.8% | 0.25% | +4.5% |
| Q4 2021 | $1,838,000 | – | 245,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |